296 related articles for article (PubMed ID: 34418405)
1. Current pharmacological approaches and potential future therapies for Celiac disease.
Kulkarni A; Patel S; Khanna D; Parmar MS
Eur J Pharmacol; 2021 Oct; 909():174434. PubMed ID: 34418405
[TBL] [Abstract][Full Text] [Related]
2. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
3. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
4. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
5. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.
Kelly CP; Green PH; Murray JA; Dimarino A; Colatrella A; Leffler DA; Alexander T; Arsenescu R; Leon F; Jiang JG; Arterburn LA; Paterson BM; Fedorak RN;
Aliment Pharmacol Ther; 2013 Jan; 37(2):252-62. PubMed ID: 23163616
[TBL] [Abstract][Full Text] [Related]
6. [Celiac disease--the chameleon among the food intolerances].
Ströhle A; Wolters M; Hahn A
Med Monatsschr Pharm; 2013 Oct; 36(10):369-80; quiz 381-2. PubMed ID: 24266248
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.
Leffler DA; Kelly CP; Abdallah HZ; Colatrella AM; Harris LA; Leon F; Arterburn LA; Paterson BM; Lan ZH; Murray JA
Am J Gastroenterol; 2012 Oct; 107(10):1554-62. PubMed ID: 22825365
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease treatment: gluten-free diet and beyond.
Mäki M
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S15-7. PubMed ID: 24979194
[TBL] [Abstract][Full Text] [Related]
9. Advances in Nonresponsive and Refractory Celiac Disease.
Malamut G; Soderquist CR; Bhagat G; Cerf-Bensussan N
Gastroenterology; 2024 Jun; 167(1):132-147. PubMed ID: 38556189
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease 2015 update: new therapies.
Veeraraghavan G; Leffler DA; Kaswala DH; Mukherjee R
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):913-27. PubMed ID: 25864708
[TBL] [Abstract][Full Text] [Related]
11. Celiac disease: from gluten to autoimmunity.
Briani C; Samaroo D; Alaedini A
Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and diagnosis of celiac disease].
Stein J
Internist (Berl); 2006 Sep; 47(9):929-37; quiz 938. PubMed ID: 16912874
[TBL] [Abstract][Full Text] [Related]
13. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for celiac disease.
Freeman HJ
Expert Opin Emerg Drugs; 2015 Mar; 20(1):129-35. PubMed ID: 25494908
[TBL] [Abstract][Full Text] [Related]
15. Celiac disease: a multi-faceted medical condition.
Domsa EM; Berindan-Neagoe I; Para I; Munteanu L; Matei D; Andreica V
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32350146
[TBL] [Abstract][Full Text] [Related]
16. Novel Nondietary Therapies for Celiac Disease.
Alhassan E; Yadav A; Kelly CP; Mukherjee R
Cell Mol Gastroenterol Hepatol; 2019; 8(3):335-345. PubMed ID: 31146067
[TBL] [Abstract][Full Text] [Related]
17. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease: Hope for new treatments beyond a gluten-free diet.
D'heedene M; Vanuytsel T; Wauters L
Clin Nutr; 2024 Jun; 43(6):1240-1249. PubMed ID: 38648685
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic approaches for celiac disease.
Vanga RR; Kelly CP
Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
[TBL] [Abstract][Full Text] [Related]
20. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
